Cincinnati Children’s Hospital director to lecture on human genome
By Courtney Kessler
ATHENS, Ohio (March 3, 2010) -- The co-director for the Computational Medicine Center at the Children’s Hospital Medical Center in Cincinnati will give a public lecture on the human genome on Tues., March 9, from 7-8:30 p.m. in Walter Hall 145.
Bruce J. Aronow, a professor of biomedical informatics at the Cincinnati Children's Research Foundation who devotes his research to how human genomes shape human health and the ability to adapt to stressful challenges, will discuss “Understanding Health and Disease in the New Era of Systems Biology.”
The lecture, sponsored by the Templeton Scholars, Cutler Scholars, the Bioinformatics Colloquium Series, and co-sponsored by the Kennedy Lecture series, will present new ways to visualize and understand health and disease by looking through the lens of the genome. Aronow will show how this will enable us to predict drugs or environmental factors that could help improve health, and cure or protect against the occurrence or worsening of different types of diseases.
Aronow will discuss how cancer, sickle cell anemia, cystic fibrosis, and allergic disorders like asthma and inflammatory bowel diseases can be understood by using the human genome -- and solved using the same methods.
Aronow’s hypothesis is that by interconnecting as much experimental and observational information as possible, we can gain new insights into the mechanisms by which different biological systems can achieve health or healthy adaptation, or undergo disease processes.
Additional lecture sponsors include the Russ College of Engineering and Technology's School of Electrical Engineering and Computer Science, Biomedical Engineering program, Center for Scientific Computing and Immersive Technologies, and Bioinformatics Laboratory; the College of Arts and Sciences' Molecular and Cellular Biology program and Department of Biological Sciences; the College of Osteopathic Medicine's Department of Biomedical Sciences; the Ohio University Genomics Facility; the Edison Biotechnical Institute; and Diagnostic Hybrids, Inc.